ArticleScience advances2021

Leukemic progenitor cells enable immunosuppression and post-chemotherapy relapse via IL-36-inflammatory monocyte axis.

He-Zhou Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.